FDA Unique Device Identification Requirement for Medical Devices

On September 24, 2013, the U.S. Food and Drug Administration(FDA) announced the new requirement to identify medical devices that affect its safe and effective use through the use of UDI.

UDI Regulation Overview

Medical Device manufacturer companies have to create and maintain the Unique Device Identifier (UDI) which is specific to a device model, and a production identifier, which includes the current production information for that specific device, such as the lot or batch number, the serial number and/or expiration date.
UDI will be a unique numeric or alphanumeric code consisting of two parts, DI – identifies the labeler and the specific version or model of the device and PI – variable portion of UDI which is combination of lot/batch number, serial number etc.

UDI Implementation Timelines

The implementation timelines for UDI are based on the level of risk the medical device has, starting from Class III, Sept, 2014 to Class I in coming years. However, many low-risk medical devices will be exempt from some or all of the requirements of the Final Rule

UDI Implementation Timelines

Source - GS1 Healthcare US® | www.gs1us.org/healthcare


Freyr Roadmap to UDI Compliance

Keeping the timelines in mind, Freyr offers a well-defined roadmap to fast-track UDI compliance comprising of a 3-step process. This process signifies Freyr’s dedication to assist and support medical device companies to attain industry compliance.

UDI Compliance

Global Unique Device Identification Data base (GUDID)

The GUDID serves as the repository of key device identification information which can be accessible by public. The DI serves as the primary key to obtain device information in database.

Global Unique Device Identification Data base

Freyr Leverage

  • 2 – 4 Week UDI Readiness Assessment
  • Complete GAP Analysis to meet project’s objectives and timelines
  • Developing an effective roadmap for UDI implementation
  • Adept Data Management (collection, collation, validation and conversion)
  • A 21 CFR Part 11 compliant ready-to-deploy UDI Software solution for effective Data Management and fast-track UDI compliance
  • Preparation and UDI Submission Status Reports
  • A robust, agile and scalable UDI system to manage complex submissions
  • Support for current and future submissions with 360° lifecycle maintenance
  • Centralized repository for audit requests and regulatory submissions
  • Creating validated HL7 SPL Submission Packages, 21 CFR Part 11 compliant

First-Time-Right Solution For 99.7% Tasks for UDI Submission

Freyr implements “Freyr IDENTITY” tool to streamline all the GUDID attributes for UDI Submissions. Download

Accurate, Efficient, Faster UDI Compliance

Freyr IDENTITY leverages the Plan, Process and Training methodology to offer an end-to-end UDI compliance solution.

Suitable for a company of any size with any number of devices, Freyr IDENTITY is exclusively designed to streamline the complete compliance process by connecting disparate internal functions and integrating data sources and formatted information with a centralized database for automated XML generation and submission that meets all the FDA regulated UDI mandates.

Click on below tab to know more about Freyr Identity

Click here


  • Under the EMA’s tight timelines, your resource has successfully delivered on commitments with overwhelming speed and decisiveness ensuring we met the requirements on time. We just wanted to recognize their hard work and diligence on the product information update for a drug. Within just few weeks of their stint at our organization, they successfully navigated our processes and integrated them into the product team. Quite impressive! We must reiterate!

    Senior Regulatory Associate, Worldwide Regulatory Strategy
    A leading research-based global Biopharmaceutical Company

  • On behalf of the entire team, I’d like to thank you for your hospitality. We understand that hosting us took time away from your day-to-day activities, and we just wanted to say thank you for everything you did to make this a very interactive, productive and successful visit for us. We would especially like to pass along our appreciation to the entire Freyr team for partnering in our mission to serve patients.

    - Director, Supplier Performance Management, Global Regulatory Affairs & Safety
    Forbes Global Top 10 Biopharma Company

  • Thanks so much for all the help and diligence. We are so impressed by the way things have been handled by Fryer and the level of competence.

    We have another very similar project coming up in the next few weeks where we need exactly the same level and type of service which we will be delighted to talk to you further.

    – Program Manager, Regulatory Affairs – Global $1Bn Pharma Company

  • Thanks for the great work you are doing, sharing the great principles that Freyr uses for its employees and your focus on sustainability.

    – Head of Procurement, Fortune 100, Global Top 10 Consumer Healthcare & Pharma Company